vs
Side-by-side financial comparison of Avalon GloboCare Corp. (ALBT) and FORMULA SYSTEMS (1985) LTD (FORTY). Click either name above to swap in a different company.
Avalon GloboCare Corp. is a global biotechnology and healthcare service provider specializing in cell and gene therapy, regenerative medicine solutions, and translational medical research. It operates across North America and Asia, serving clinical, research and commercial healthcare stakeholders with tailored offerings.
Formula Systems (1985) Ltd. is a publicly traded holding company headquartered in Or Yehuda, Israel. Through its subsidiaries it operates mainly in the area of information technology. Shares of Formula Systems are traded on the NASDAQ Global Select Market and on the Tel Aviv Stock Exchange. In 2010 Polish software maker Asseco acquired a 50.2% stake in the company.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $350.1K | — | ||
| Q2 25 | $350.4K | — | ||
| Q1 25 | $349.8K | — | ||
| Q4 24 | $345.8K | — | ||
| Q3 24 | $345.2K | — | ||
| Q2 24 | $327.9K | — | ||
| Q1 24 | $314.6K | — | ||
| Q4 23 | $321.3K | — |
| Q3 25 | $-254.3K | — | ||
| Q2 25 | $-13.5M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-1.4M | — | ||
| Q4 23 | $-9.6M | — |
| Q3 25 | -21.8% | — | ||
| Q2 25 | -1109.6% | — | ||
| Q1 25 | -516.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -367.9% | — | ||
| Q2 24 | -458.8% | — | ||
| Q1 24 | -268.0% | — | ||
| Q4 23 | -3047.1% | — |
| Q3 25 | -72.6% | — | ||
| Q2 25 | -3840.9% | — | ||
| Q1 25 | -709.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -486.5% | — | ||
| Q2 24 | -650.2% | — | ||
| Q1 24 | -434.7% | — | ||
| Q4 23 | -2973.7% | — |
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $-6.22 | — | ||
| Q1 25 | $-1.43 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.82 | — | ||
| Q2 24 | $-2.85 | — | ||
| Q1 24 | $-1.86 | — | ||
| Q4 23 | $-21.18 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
